06 October 2022
IP Perspectives Euskadi V (in Spanish) – 6 October | Face-to-Face | Bilbao
Hotel Catalonia Gran Vía de Bilbao
News & Events
Next events
No event found!
Relevant news
Our IP Blog
UPC Agreement ruled unconstitutional in Hungary
ABG IP
03/07/2018
On 29th June 2018, the Hungarian Constitutional Court published on the Court’s website a decision ruling that UPC Agreement deprives the Hungarian courts from having competence for judicial review on
Peptomyc S.L. wins the Best Business Initiative Award at the 25th Young Entrepreneur Awards
ABG IP
28/06/2018
The Independent Association of Young Entrepreneurs of Catalonia (AIJEC) has awarded the Award for the Best Business Initiative of its 25th edition to Peptomyc. Peptomyc is a spin-off of
Four Patent IP STARS at ABG IP
ABG IP
27/06/2018
Managing Intellectual Property IP STARS published the lists of the highly recommended IP practitioners in private practice. Four partners of ABG Patentes Juan Arias, Francisco Bernardo, José Miguel Lissén and Fernando
ABG IP again in top position in IAM Patents 1000 – The World’s Leading Patent Practitioners 2018 for the seventh consecutive year
ABG IP
21/06/2018
ABG IP is pleased to announce that it has again been ranked as “highly recommended Intellectual Property firm in Spain” according to the magazine Intellectual Asset Management (IAM). ABG
Successful ABG Patentes seminar “IP Perspectives IV”
ABG IP
20/06/2018
On June 7, 2018, ABG IP organized the fourth edition of the “IP Perspectives” seminar, which took place at the NH Paseo de la Habana Hotel in Madrid.
European Commission proposes to modify the Regulation of SCPs
Marta Rodríguez
01/06/2018
Last 28.05.2018 the European Commission published a Proposal of Regulation to modify Regulation No. 469/2009 on Supplementary Protection Certificates for medicaments. Basically, the proposal contemplates that, for SPCs granted
Spherium Biomed announces positive outcome of a phase I/IIa clinical trial for Mucomel®
ABG IP
22/05/2018
Spherium Biomed announced on May 17, 2018 that it has obtained positive results with its new drug Mucomel® in a phase I/IIa clinical trial for the
UK Ratifies Unified Patent Court Agreement
ABG IP
27/04/2018
The United Kingdom announced on 26 April 2018, World Intellectual Property Day, that it has deposited the instruments of ratification of the Agreement relating to
Spherium Biomed completed enrolment in the Cyclatop© (SP14019) trial in February 2018
ABG IP
24/04/2018
This phase IIa clinical study in paediatric and adult patients with mild to moderate atopic dermatitis is designed as a proof-of-concept, multi-centre, randomised, double-blind, vehicle-controlled
Spherium Biomed has signed a licensing agreement with Simini Technologies from Canada
ABG IP
19/04/2018
Spherium Biomed has recently signed a licensing agreement with Simini Technologies from Ontario (Canada) to develop veterinarian applications based on the Spherium’s proprietary topical cyclosporine (SP14019).
ABG Patentes seminar “IP Perspectives IV”
ABG IP
23/03/2018
We are pleased to announce that ABG Patentes will be hosting the fourth edition of the “IP Perspectives” seminar, which will be held on Thursday, 7 June 2018 at
Atlas Molecular Pharma, approval for the treatment of Congenital Erythropoietic Porphyria
ABG IP
15/03/2018
Atlas Molecular Pharma, a private company founded in 2015 in Derio (Spain) as a spin-off from the Centre for Co-operative Research in Biosciences (CIC bioGUNE), receives approval
